Description
L-694,247 is an agonist of the serotonin (5-HT) receptor subtype 5-HT1D.1 It is selective for 5-HT1D over the 5-HT1A, 5-HT1C, 5-HT1E, 5-HT2, and 5-HT3 receptors (Kis = 0.093, 2.29, 380, 2,187, 316, and >10,000 nM, respectively). L-694,247 inhibits adenylyl cyclase activity induced by forskolin (Item No. 11018) in guinea pig substantia nigra homogenates and potassium-induced 5-HT release in isolated guinea pig frontal cortex strips (EC50s = 0.79 and 0.4 nM, respectively). It decreases water intake in dehydrated rats as well as prevents carbachol-, angiotensin II-, or isoproterenol-induced increases in water intake in normohydrated rats in a dose-dependent manner.2 Intra-atrial administration of L-694,247 (0.00000125-0.1 µg/kg) decreases renal perfusion pressure but does not affect systolic blood pressure or heart rate in in situ autoperfused rat kidney infused with phenylephrine (Item Nos. 17205 | 18619).3WARNING This product is not for human or veterinary use.
References
[1] M.S. BEER. L-694,247: a potent 5-HT1D receptor agonist[J]. British Journal of Pharmacology, 1993, 110 3: 1196-1200. DOI:
10.1111/j.1476-5381.1993.tb13941.x[2] E DE CASTRO-E SILVA . Effect of Third Ventricle Administration of L-694,247, a Selective 5-HT1D Receptor Agonist, on Water Intake in Rats[J]. Pharmacology Biochemistry and Behavior, 1997, 57 4: Pages 749-754. DOI:
10.1016/s0091-3057(96)00457-1[3] JOSÉ-ÁNGEL GARCÍA-PEDRAZA. Pharmacological evidence that 5-HT1D activation induces renal vasodilation by NO pathway in rats[J]. Clinical and Experimental Pharmacology and Physiology, 2015, 42 6: 640-647. DOI:
10.1111/1440-1681.12397